• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重新审视 COVID-19 政策:接下来该怎么做的 10 项基于证据的建议。

Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here.

机构信息

Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.

Department of Family and Community Medicine, School of Medicine, University of California, San Francisco, CA, USA.

出版信息

BMC Public Health. 2021 Nov 13;21(1):2084. doi: 10.1186/s12889-021-12082-z.

DOI:10.1186/s12889-021-12082-z
PMID:34774012
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8590121/
Abstract

BACKGROUND

Strategies to control coronavirus 2019 disease (COVID-19) have often been based on preliminary and limited data and have tended to be slow to evolve as new evidence emerges. Yet knowledge about COVID-19 has grown exponentially, and the expanding rollout of vaccines presents further opportunity to reassess the response to the pandemic more broadly.

MAIN TEXT

We review the latest evidence concerning 10 key COVID-19 policy and strategic areas, specifically addressing: 1) the expansion of equitable vaccine distribution, 2) the need to ease restrictions as hospitalization and mortality rates eventually fall, 3) the advantages of emphasizing educational and harm reduction approaches over coercive and punitive measures, 4) the need to encourage outdoor activities, 5) the imperative to reopen schools, 6) the far-reaching and long-term economic and psychosocial consequences of sustained lockdowns, 7) the excessive focus on surface disinfection and other ineffective measures, 8) the importance of reassessing testing policies and practices, 9) the need for increasing access to outpatient therapies and prophylactics, and 10) the necessity to better prepare for future pandemics.

CONCLUSIONS

While remarkably effective vaccines have engendered great hope, some widely held assumptions underlying current policy approaches call for an evidence-based reassessment. COVID-19 will require ongoing mitigation for the foreseeable future as it transforms from a pandemic into an endemic infection, but maintaining a constant state of emergency is not viable. A more realistic public health approach is to adjust current mitigation goals to be more data-driven and to minimize unintended harms associated with unfocused or ineffective control efforts. Based on the latest evidence, we therefore present recommendations for refining 10 key policy areas, and for applying lessons learned from COVID-19 to prevent and prepare for future pandemics.

摘要

背景

控制 2019 年冠状病毒病(COVID-19)的策略通常基于初步和有限的数据,并且随着新证据的出现,往往演变缓慢。然而,COVID-19 的知识呈指数级增长,疫苗的广泛推出为更广泛地重新评估对大流行的应对提供了进一步的机会。

主要文本

我们回顾了有关 COVID-19 政策和战略的 10 个关键领域的最新证据,具体涉及:1)扩大公平疫苗分配,2)随着住院和死亡率最终下降,需要放宽限制,3)强调教育和减少伤害方法优于强制性和惩罚性措施的优势,4)需要鼓励户外活动,5)必须重新开放学校,6)长期封锁对经济和社会心理的深远和长期影响,7)过分关注表面消毒和其他无效措施,8)重新评估检测政策和实践的重要性,9)增加获得门诊治疗和预防措施的机会,10)更好地为未来的大流行做准备的必要性。

结论

虽然效果显著的疫苗带来了巨大的希望,但当前政策方法所依据的一些广泛持有的假设需要进行基于证据的重新评估。由于 COVID-19 将从大流行转变为地方病,因此在可预见的未来仍将需要持续缓解,但保持持续的紧急状态是不可行的。更现实的公共卫生方法是调整当前缓解目标,使其更加以数据为导向,并最大限度地减少与无重点或无效控制措施相关的意外危害。基于最新证据,我们因此提出了改进 10 个关键政策领域的建议,并为预防和应对未来的大流行应用从 COVID-19 中吸取的经验教训。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a05b/8590348/b50abc05465e/12889_2021_12082_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a05b/8590348/b50abc05465e/12889_2021_12082_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a05b/8590348/b50abc05465e/12889_2021_12082_Fig1_HTML.jpg

相似文献

1
Revisiting COVID-19 policies: 10 evidence-based recommendations for where to go from here.重新审视 COVID-19 政策:接下来该怎么做的 10 项基于证据的建议。
BMC Public Health. 2021 Nov 13;21(1):2084. doi: 10.1186/s12889-021-12082-z.
2
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为控制 COVID-19 疫情而采取的措施。
Cochrane Database Syst Rev. 2022 Jan 17;1(1):CD015029. doi: 10.1002/14651858.CD015029.
3
Measures implemented in the school setting to contain the COVID-19 pandemic.学校为遏制新冠疫情而采取的措施。
Cochrane Database Syst Rev. 2024 May 2;5(5):CD015029. doi: 10.1002/14651858.CD015029.pub2.
4
Assessing COVID-19 pandemic policies and behaviours and their economic and educational trade-offs across US states from Jan 1, 2020, to July 31, 2022: an observational analysis.评估 2020 年 1 月 1 日至 2022 年 7 月 31 日美国各州的 COVID-19 大流行政策和行为及其经济和教育方面的权衡取舍:一项观察性分析。
Lancet. 2023 Apr 22;401(10385):1341-1360. doi: 10.1016/S0140-6736(23)00461-0. Epub 2023 Mar 23.
5
Unintended consequences of measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.学校为控制 COVID-19 大流行而实施的措施产生的意外后果:范围综述。
Cochrane Database Syst Rev. 2022 Jun 6;6(6):CD015397. doi: 10.1002/14651858.CD015397.
6
Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review.学校为遏制新冠疫情而采取的措施:一项范围综述
Cochrane Database Syst Rev. 2020 Dec 17;12(12):CD013812. doi: 10.1002/14651858.CD013812.
7
Long term care facilities in England during the COVID-19 pandemic-a scoping review of guidelines, policy and recommendations.新冠疫情期间英国的长期护理机构——对指南、政策及建议的范围界定审查
BMC Geriatr. 2024 May 3;24(1):394. doi: 10.1186/s12877-024-04867-9.
8
Weighing policymaking: A narrative review of school closures as COVID-19 pandemic-mitigation strategies.权衡决策:学校关闭作为 COVID-19 大流行缓解策略的叙述性综述。
Pediatr Pulmonol. 2022 Sep;57(9):1982-1989. doi: 10.1002/ppul.25787. Epub 2021 Dec 20.
9
Association of Simulated COVID-19 Policy Responses for Social Restrictions and Lockdowns With Health-Adjusted Life-Years and Costs in Victoria, Australia.模拟澳大利亚维多利亚州新冠疫情政策对社会限制和封锁措施的反应与健康调整生命年和成本的关系。
JAMA Health Forum. 2021 Jul 30;2(7):e211749. doi: 10.1001/jamahealthforum.2021.1749. eCollection 2021 Jul.
10
Return-to-work, disabilities and occupational health in the age of COVID-19.新冠疫情时代的重返工作岗位、残疾与职业健康。
Scand J Work Environ Health. 2021 Jul 1;47(5):408-409. doi: 10.5271/sjweh.3960. Epub 2021 May 18.

引用本文的文献

1
The global response to the pandemic: An empirical cluster analysis of policies targeting COVID-19.全球对疫情的应对:针对新冠疫情政策的实证聚类分析
PLoS One. 2025 May 15;20(5):e0322692. doi: 10.1371/journal.pone.0322692. eCollection 2025.
2
The impact of Covid-19 on harm reduction policies in Iran: an interrupted time series analysis.新冠疫情对伊朗减少伤害政策的影响:一项中断时间序列分析。
Harm Reduct J. 2025 Jan 7;22(1):3. doi: 10.1186/s12954-024-01137-0.
3
Masking for COVID-19 and other respiratory viral infections: implications of the available evidence.

本文引用的文献

1
THE ECONOMIC IMPACTS OF COVID-19: EVIDENCE FROM A NEW PUBLIC DATABASE BUILT USING PRIVATE SECTOR DATA.新冠疫情的经济影响:来自利用私营部门数据构建的新公共数据库的证据。
Q J Econ. 2024 May;139(2):829-889. doi: 10.1093/qje/qjad048. Epub 2023 Oct 4.
2
A Harm-Reduction Approach to Coronavirus Disease 2019 (COVID-19)-Safer Socializing.一种针对2019冠状病毒病(COVID-19)的减少危害方法——更安全的社交方式
JAMA Health Forum. 2020 Jun 1;1(6):e200656. doi: 10.1001/jamahealthforum.2020.0656.
3
Competing health risks associated with the COVID-19 pandemic and early response: A scoping review.
针对新冠病毒及其他呼吸道病毒感染的口罩使用:现有证据的影响
Antimicrob Steward Healthc Epidemiol. 2024 May 3;4(1):e73. doi: 10.1017/ash.2024.67. eCollection 2024.
4
To vaccinate or to isolate? Establishing which intervention leads to measurable mortality reduction during the COVID-19 Delta wave in Poland.接种疫苗还是隔离?在 COVID-19 德尔塔波期间,波兰确定哪种干预措施可降低可衡量的死亡率。
Front Public Health. 2023 Sep 7;11:1221964. doi: 10.3389/fpubh.2023.1221964. eCollection 2023.
5
Which Factors Were Related to the Number of COVID-19 Cases in the 2022/2023 Season Compared to the 2021/2022 Season in Europe?与2021/2022赛季相比,2022/2023赛季欧洲新冠病毒病病例数与哪些因素相关?
J Clin Med. 2023 Jul 6;12(13):4517. doi: 10.3390/jcm12134517.
6
Experiences of aftermath of COVID-19 in relation to social, financial and health related aspects among previously hospitalized patients: a qualitative exploration.COVID-19 后经历与先前住院患者社会、财务和健康相关方面的关系:定性探索。
Front Public Health. 2023 Jun 15;11:1196810. doi: 10.3389/fpubh.2023.1196810. eCollection 2023.
7
COVID-19 vaccination and governance in the case of low, middle and high-income countries.新冠病毒疫苗接种和低、中、高收入国家的治理。
BMC Public Health. 2023 Jun 5;23(1):1073. doi: 10.1186/s12889-023-15975-3.
8
Impact of the COVID-19 pandemic on children and adolescents: determinants and association with quality of life and mental health-a cross-sectional study.2019年冠状病毒病大流行对儿童和青少年的影响:决定因素及其与生活质量和心理健康的关联——一项横断面研究
Child Adolesc Psychiatry Ment Health. 2023 Feb 1;17(1):17. doi: 10.1186/s13034-023-00563-5.
9
Humoral and T-cell response 12 months after the first BNT162b2 vaccination in solid organ transplant recipients and controls: Kinetics, associated factors, and role of SARS-CoV-2 infection.在实体器官移植受者和对照者中,首次接种 BNT162b2 疫苗 12 个月后的体液和 T 细胞反应:动力学、相关因素和 SARS-CoV-2 感染的作用。
Front Immunol. 2023 Jan 13;13:1075423. doi: 10.3389/fimmu.2022.1075423. eCollection 2022.
10
An Examination of US COVID-19 Vaccine Distribution in New Jersey, Pennsylvania, and New York.美国新泽西州、宾夕法尼亚州和纽约州的 COVID-19 疫苗分配情况研究
Int J Environ Res Public Health. 2022 Nov 24;19(23):15629. doi: 10.3390/ijerph192315629.
与 COVID-19 大流行和早期应对相关的健康风险竞争:范围综述。
PLoS One. 2022 Aug 29;17(8):e0273389. doi: 10.1371/journal.pone.0273389. eCollection 2022.
4
Extended interval BNT162b2 vaccination enhances peak antibody generation.延长间隔接种BNT162b2疫苗可增强抗体峰值生成。
NPJ Vaccines. 2022 Jan 27;7(1):14. doi: 10.1038/s41541-022-00432-w.
5
Impact of community masking on COVID-19: A cluster-randomized trial in Bangladesh.社区戴口罩对 COVID-19 的影响:孟加拉国的一项集群随机试验。
Science. 2022 Jan 14;375(6577):eabi9069. doi: 10.1126/science.abi9069.
6
COVID-19 doesn't need lockdowns to destroy jobs: The effect of local outbreaks in Korea.新冠疫情无需封锁措施就能导致就业岗位减少:韩国局部疫情的影响。
Labour Econ. 2021 Jun;70:101993. doi: 10.1016/j.labeco.2021.101993. Epub 2021 Apr 30.
7
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.BNT162b2 mRNA 疫苗标准和延长给药间隔的免疫原性。
Cell. 2021 Nov 11;184(23):5699-5714.e11. doi: 10.1016/j.cell.2021.10.011. Epub 2021 Oct 16.
8
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Dose, Infection, and Disease Outcomes for Coronavirus Disease 2019 (COVID-19): A Review.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)对于 2019 年冠状病毒病(COVID-19)的剂量、感染和疾病结果:综述。
Clin Infect Dis. 2022 Aug 24;75(1):e1195-e1201. doi: 10.1093/cid/ciab903.
9
Vaccinating people who have had covid-19: why doesn't natural immunity count in the US?为感染过新冠病毒的人接种疫苗:在美国,为什么自然免疫不算数?
BMJ. 2021 Sep 13;374:n2101. doi: 10.1136/bmj.n2101.
10
T cell-oriented strategies for controlling the COVID-19 pandemic.以 T 细胞为导向的策略控制 COVID-19 大流行。
Nat Rev Immunol. 2021 Nov;21(11):687-688. doi: 10.1038/s41577-021-00625-9.